Sosei teams up with Abbvie on neurological drug discovery
Drug Discovery World
AUGUST 4, 2022
Biopharmaceutical group Sosei will work together with AbbVie on a drug discovery project to discover, develop and commercialise small molecules that target neurological diseases. . Matt Barnes, Head of UK Research & Development, Sosei Heptares said:? “We Sosei will put forward its Heptares’?StaR regulatory ?and
Let's personalize your content